文献速递头颈外科咽喉与嗓音

喉咽癌放疗后放射性坏死的炎症标志物意义

Significance of Inflammation Marker of Radionecrosis in Laryngopharynx Cancer Treated With Radiation.
PubMed 文献 · Laryngoscope · 2025-08-28

这项回顾性研究纳入2013年1月至2020年12月在一家三级转诊中心以放疗为基础治疗喉癌及下咽癌的219例患者,其中20例(9.1%)发生需住院治疗的放射性坏死(Chandler分级3或4级)。单因素分析显示放射性坏死与临床晚期T分期、甲状软骨受累、声门旁侵犯、初始治疗方式(单纯放疗与放化疗)及放疗中期中性粒细胞与淋巴细胞比值(最佳截断值2.4)显著相关。发生放射性坏死的20例患者中,9例未手术恢复、4例仅手术后恢复、7例未改善;结局较好者倾向于更早接受高压氧治疗且放疗中期NLR较低。

要点

  • 219例喉癌及下咽癌患者中20例(9.1%)发生需住院的放射性坏死(Chandler分级3或4级)。
  • 放射性坏死与临床晚期T分期、甲状软骨受累、声门旁侵犯、初始治疗方式及放疗中期NLR(最佳截断值2.4)显著相关。
  • 20例放射性坏死患者中9例未手术恢复、4例仅手术后恢复、7例未改善;结局较好者倾向于更早接受高压氧治疗且放疗中期NLR较低。

核心结论

  • 肿瘤状态晚期且放疗中期NLR升高的患者应密切监测放射性坏死,早期高压氧治疗干预可能提高器官保留率。

研究设计与样本

  • 回顾性研究,纳入2013年1月至2020年12月在一家三级转诊中心以放疗为基础治疗作为初始方式的喉癌及下咽癌患者,共219例。

主要发现

  • 219例患者中20例(9.1%)发生需住院治疗的放射性坏死(Chandler分级3或4级)。
  • 单因素分析显示放射性坏死与临床晚期T分期、甲状软骨受累、声门旁侵犯、初始治疗方式(单纯放疗与放化疗)及放疗中期中性粒细胞与淋巴细胞比值(最佳截断值2.4)显著相关。
  • 20例接受治疗的放射性坏死患者(包括接受高压氧治疗者)中,9例未手术恢复,4例仅手术后恢复,7例未改善。
  • 结局较好的患者倾向于更早接受高压氧治疗,且放疗中期NLR值较低。

临床怎么用

  • 作者认为,肿瘤状态晚期且放疗中期NLR升高的患者应密切监测放射性坏死,早期高压氧治疗干预可能提高器官保留率。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Radiotherapy is an effective treatment modality for head and neck cancer; however, it is associated with various side effects. One of the most devastating complications in the laryngopharyngeal region is radionecrosis, which presents with various signs and symptoms and can significantly impair patients' quality of life. This study aimed to identify factors related to the occurrence of radionecrosis and to evaluate treatment outcomes based on clinical experience. METHODS: This retrospective study included patients diagnosed with laryngeal and hypopharyngeal cancer who received radiotherapy-based treatments as the initial modality at our tertiary referral center from January 2013 to December 2020. RESULTS: A total of 219 patients were included, of whom 20 (9.1%) developed radionecrosis requiring admission for treatment (Chandler's grade 3 or 4). Univariate analysis revealed significant associations between radionecrosis and clinically advanced T stage, thyroid cartilage involvement, paraglottic invasion, primary treatment modality (radiotherapy alone vs. chemoradiotherapy), and mid-radiation neutrophil-to-lymphocyte ratio (optimal cutoff; 2.4). Among the 20 patients treated for radionecrosis, including those who received hyperbaric oxygen (HBO) therapy, nine recovered without surgery, four recovered only after surgery, and seven did not improve. Patients with better outcomes tended to receive HBO therapy earlier and exhibited lower mid-radiation NLR values. CONCLUSION: Patients with an advanced tumor status and elevated mid-radiation NLR should be closely monitored for radionecrosis. This suggests that early intervention with HBO therapy may enhance the rate of organ preservation.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Kim JH, Yi SE, Kwon M, et al. Significance of Inflammation Marker of Radionecrosis in Laryngopharynx Cancer Treated With Radiation. Laryngoscope. 2025. PMID: 40874727. doi:10.1002/lary.70071

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。